NCT06239688 Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce
| NCT ID | NCT06239688 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of North Carolina, Chapel Hill |
| Condition | Aging |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,764 participants |
| Start Date | 2024-04-12 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,764 participants in total. It began in 2024-04-12 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will compare two training models of an evidence-based online dementia care training program for direct care staff in assisted living to a waitlist control: 1) essentiALZ training and 2) essentiALZ training + Project ECHO. It will examine the extent to which each model is implemented and achieves its intended outcomes to improve staff knowledge and attitudes, change care practices, and improve the wellbeing of staff, residents, and residents' family members. Results will inform next steps in dementia care training for the assisted living (AL) and broader long-term care workforce. To examine these outcomes, data will be collected from AL staff and families over the course of 6 months. Staff will complete questionnaires and participate in interviews (as applicable) at baseline, post-training, 3-months, and 6-months. Families will participate in interviews at baseline, 3-months, and 6-months.
Eligibility Criteria
Inclusion Criteria: AL Staff: * Staff (part-time, full-time, and including contract staff) who provide direct care to residents at the participating assisted living community (e.g., certified nursing assistants, personal care aides, registered nurses, licensed practical nurses, activity directors, social workers, and others) as determined by the administrator/health care supervisor * Are 18 years of age or older * Are able to read and speak English fluently Family: * Resident not expected to die or be transferred in the next six months at baseline * At follow-up, resident lived in AL community at least one month during the three months prior to interview date * Are a family member/legally authorized representative (LAR), or designated contact of a resident with Alzheimer's disease and related dementia (ADRD) of a participating AL community * Are 18 years of age or older * Are English speaking * Visit the resident at least monthly Exclusion Criteria: AL Staff \& Family: \- Are under 18 years of age
Contact & Investigator
Sheryl Zimmerman, PhD
PRINCIPAL INVESTIGATOR
University of North Carolina, Chapel Hill
Frequently Asked Questions
Who can join the NCT06239688 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06239688 currently recruiting?
Yes, NCT06239688 is actively recruiting participants. Contact the research team at jvtsilbersack@unc.edu for enrollment information.
Where is the NCT06239688 trial being conducted?
This trial is being conducted at Chapel Hill, United States.
Who is sponsoring the NCT06239688 clinical trial?
NCT06239688 is sponsored by University of North Carolina, Chapel Hill. The principal investigator is Sheryl Zimmerman, PhD at University of North Carolina, Chapel Hill. The trial plans to enroll 1,764 participants.